Cargando…
Investigation of the inhibitory effects of HA-1077 and Y-32885 on the translocation of PKCbetaI, PKCbetaII and PKCzeta in human neutrophils.
To transmit the information inside the cell, one possibility is the action of an enzyme called kinase that phosphorylates other proteins. To study these enzymes, chemical compound synthesis was needed to know the function and the mechanism of activation. The major difficulty is creating a specific m...
Autores principales: | Siomboing, X, Gressier, B, Dine, T, Brunet, C, Luyckx, M, Cazin, M, Cazin, J C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781726/ https://www.ncbi.nlm.nih.gov/pubmed/11817672 |
Ejemplares similares
-
Preclinical Efficacy of INST3399, a Synthetic Novel PKCbeta Inhibitor, for the Treatment of Obesity and Fatty Liver Disease
por: Mehta, Kamal
Publicado: (2022) -
The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells
por: Abe, Hideyuki, et al.
Publicado: (2014) -
IGFBP-3 reduces eNOS and PKCzeta phosphorylation, leading to lowered VEGF levels
por: Zhang, Qiuhua, et al.
Publicado: (2015) -
Activation of PKCzeta and PKMzeta in the Nucleus Accumbens Core Is Necessary for the Retrieval, Consolidation and Reconsolidation of Drug Memory
por: Crespo, Jose A., et al.
Publicado: (2012) -
Mecánica 1
por: Cazin, Michel
Publicado: (1979)